According to Ys Biopharma latest financial reports the total debt is $42.35M, an increase of 13.46% to 2022. At the end of 2022 company had $37.33M total debt. This figure represents the debts and financial obligations that Ys Biopharma combine short-term debt, long-term debt, and other fixed payment obligations (such as capital leases) of a business that are incurred while under normal operating cycles.
Year | Total debt | Change |
---|---|---|
2023 | $42.35M | 13.46% |
2022 | $37.33M | - |
2021 | $2.07M | - |